Clinical significance of microRNAs in chronic and acute human leukemia CH Yeh, R Moles, C Nicot Molecular cancer 15, 1-16, 2016 | 159 | 2016 |
STAT1: A novel target of miR-150 and miR-223 is involved in the proliferation of HTLV-I–transformed and ATL cells R Moles, M Bellon, C Nicot Neoplasia 17 (5), 449-462, 2015 | 64 | 2015 |
MicroRNAs-based therapy: a novel and promising strategy for cancer treatment. R Moles MicroRNA (Shariqah, United Arab Emirates) 6 (2), 102-109, 2017 | 39 | 2017 |
The emerging role of miRNAs in HTLV-1 infection and ATLL pathogenesis R Moles, C Nicot Viruses 7 (7), 4047-4074, 2015 | 38 | 2015 |
Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia CH Yeh, XT Bai, R Moles, L Ratner, TA Waldmann, T Watanabe, C Nicot Molecular cancer 15, 1-7, 2016 | 37 | 2016 |
Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells XT Bai, R Moles, H Chaib-Mezrag, C Nicot Journal of hematology & oncology 8, 1-12, 2015 | 34 | 2015 |
WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells R Moles, XT Bai, H Chaib-Mezrag, C Nicot Journal of Hematology & Oncology 9, 1-11, 2016 | 30 | 2016 |
Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence S Sarkis, V Galli, R Moles, D Yurick, G Khoury, DFJ Purcell, G Franchini, ... Retrovirology 16, 1-14, 2019 | 23 | 2019 |
p30 protein: a critical regulator of HTLV-1 viral latency and host immunity R Moles, S Sarkis, V Galli, M Omsland, DFJ Purcell, D Yurick, G Khoury, ... Retrovirology 16, 1-15, 2019 | 22 | 2019 |
JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells M Bellon, R Moles, H Chaib-Mezrag, J Pancewicz, C Nicot Journal of Hematology & Oncology 11, 1-12, 2018 | 20 | 2018 |
On enzyme‐based anticancer molecular dietary manipulations A Sapone, D Canistro, S Melega, R Moles, F Vivarelli, M Paolini BioMed Research International 2012 (1), 790987, 2012 | 17 | 2012 |
NK cells and monocytes modulate primary HTLV-1 infection R Moles, S Sarkis, V Galli, M Omsland, M Artesi, M Bissa, K McKinnon, ... PLoS Pathogens 18 (4), e1010416, 2022 | 15 | 2022 |
HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC M Bissa, S Kim, V Galli, S Fourati, S Sarkis, A Arakelyan, IS de Castro, ... Nature communications 14 (1), 575, 2023 | 11 | 2023 |
Functional properties and sequence variation of HTLV-1 p13 M Omsland, M Silic-Benussi, R Moles, S Sarkis, DFJ Purcell, D Yurick, ... Retrovirology 17, 1-12, 2020 | 10 | 2020 |
Transient viral activation in human T cell leukemia virus type 1-infected macaques treated with Pomalidomide A Gutowska, K McKinnon, S Sarkis, MN Doster, M Bissa, R Moles, ... Frontiers in Medicine 9, 897264, 2022 | 7 | 2022 |
Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques MA Rahman, M Bissa, I Silva de Castro, S Helmold Hait, JD Stamos, ... Nature Microbiology 8 (5), 905-918, 2023 | 4 | 2023 |
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells M Bissa, V Galli, L Schifanella, M Vaccari, MA Rahman, G Gorini, ... Vaccines 11 (11), 1662, 2023 | 1 | 2023 |
Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells A Gutowska, S Sarkis, MA Rahman, KC Goldfarbmuren, R Moles, M Bissa, ... Pathogens 13 (4), 292, 2024 | | 2024 |
Publisher Correction: Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques MA Rahman, M Bissa, IS de Castro, SH Hait, JD Stamos, F Bhuyan, ... Nature Microbiology 8 (8), 1600, 2023 | | 2023 |
A-102 Do biological differences exist between HTLV-1A and HTLV-1C? D Fujikawa, R Moles, M Omsland, D Purcell, V Galli, G Franchini JAIDS Journal of Acquired Immune Deficiency Syndromes 81, 30, 2019 | | 2019 |